Rochem Methotrexate Rochem Methotrexate

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of USP Standards of Tox21_300269 on PharmaCompass.com.

    Client Email Product

    Tox21_300269

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    45
    US DMFs Filed

    US DMFs Filed

    20
    CEP/COS Certifications

    CEP/COS Certifications

    7
    JDMFs Filed

    JDMFs Filed

    4
    Other Certificates

    Other Certificates

    3
    Other Suppliers

    Other Suppliers

    24
    API REF. PRICE (USD / KG)
    4,119

    API Market Place

    16
    INTERMEDIATES
    6
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    126
    Europe

    Europe

    289
    Canada

    Canada

    38
    Australia

    Australia

    45
    South Africa

    South Africa

    12
    Uploaded Dossiers

    Uploaded Dossiers

    53
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    1,157.00

    Annual Reports

    0

    FDF Market Place

    23
    EXCIPIENTS
    212
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    135

    USFDA Exclusivities

    2
    DIGITAL CONTENT

    Blog #PharmaFlow

    3

    News

    117
    REF STANDARD

    EDQM

    6

    USP

    5

    JP

    4

    Other Listed Suppliers

    6
    SERVICES

    0

    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info

    USP

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Methotrexate Related Compound C (50 mg) ((S)-2-(4-{[(2-...

      PDF Supplier PDF
      URL Supplier Web Content
      1414036
      2410-93-7
      R01910
      F0H357 (30-SEP-2016)
      805
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      USP

      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Methotrexate Related Compound B (75 mg) ((S)-2-{4-[(2,4...

        PDF Supplier PDF
        URL Supplier Web Content
        1414025
        54-62-6
        R02860
        H0M151 (30-NOV-2016)
        900
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content

        USP

        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Methotrexate (500 mg)

          PDF Supplier PDF
          URL Supplier Web Content
          1414003
          59-05-2
          R020L0
          K0M020 (31-AUG-2016)
          230
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          USP

          Contact Supplier
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            Methotrexate System Suitability Mixture (5 mg)

            PDF Supplier PDF
            URL Supplier Web Content
            1413999
            N/A
            F1J403
            F0J403 (30-JUN-2015)
            730
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            USP

            Contact Supplier
              Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
              Post an Enquiry Post an Enquiry
              Flag U.S.A
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              R-Methotrexate (5 mg) ((R)-2-(4-{[(2,4-diaminopteridin-...

              PDF Supplier PDF
              URL Supplier Web Content
              1413988
              59-05-2
              R001Q0
              F0J368 (31-AUG-2015)
              805
              ASK
              US
              PHARMACOMPASS
              Upload
              your Marketing & Sales content
              left grey arrow
              right gray arrow
              • INJECTABLE;INJECTION - EQ 100MG BASE/VIAL
              • INJECTABLE;INJECTION - EQ 1GM BASE/VIAL
              • INJECTABLE;INJECTION - EQ 1GM BASE/40ML (EQ 25MG BASE/ML)
              • INJECTABLE;INJECTION - EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML)
              • INJECTABLE;INJECTION - EQ 2.5MG BASE/ML
              • INJECTABLE;INJECTION - EQ 20MG BASE/VIAL
              • INJECTABLE;INJECTION - EQ 20MG BASE/2ML (EQ 10MG BASE/ML)
              • INJECTABLE;INJECTION - EQ 25MG BASE/ML
              • INJECTABLE;INJECTION - EQ 500MG BASE/20ML (EQ 25MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
              • INJECTABLE;INJECTION - EQ 50MG BASE/VIAL
              • INJECTABLE;INJECTION - EQ 50MG BASE/2ML (EQ 25MG BASE/ML)
              • SOLUTION;SUBCUTANEOUS - 10MG/0.4ML (10MG/0.4ML)
              • SOLUTION;SUBCUTANEOUS - 12.5MG/0.5ML (12.5MG/0.5ML)
              • SOLUTION;SUBCUTANEOUS - 15MG/0.6ML (15MG/0.6ML)
              • SOLUTION;SUBCUTANEOUS - 17.5MG/0.7ML (17.5MG/0.7ML)
              • SOLUTION;SUBCUTANEOUS - 20MG/0.8ML (20MG/0.8ML)
              • SOLUTION;SUBCUTANEOUS - 22.5MG/ML (22.5MG/ML)
              • SOLUTION;SUBCUTANEOUS - 25MG/1ML (25MG/1ML)
              • SOLUTION;SUBCUTANEOUS - 7.5MG/0.3ML (7.5MG/0.3ML)
              • TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
              Ask Us for Pharmaceutical Supplier and Partner
              Ask Us, Find A Supplier / Partner
              No Commissions, No Strings Attached, Get Connected for FREE

              What are you looking for?

              How can we help you?

              The request can't be empty

              Please read our Privacy Policy carefully

              You must agree to the privacy policy

              The name can't be empty
              The company can't be empty.
              The email can't be empty Please enter a valid email.
              The mobile can't be empty
              Fermion Methotrexate

              Access Virtual Booth

              Contact Supplier

              View Presentation

              Avra Methotrexate RM

              Access Virtual Booth

              Contact Supplier

              View Presentation

              Post Enquiry
              POST ENQUIRY

              Market Place

              Market Place

              PharmaCompass

              Home

              Market Place

              Menu

              Post Enquiry

              Post Enquiry

              Market Place

              Market Place

              Search